Press releasePRNewswire
Shoulder Innovations
SI · NYSE
$18.72+$0.47 (+2.58%)TodayMarket closed ·
Prev close $18.25
Latest news
- News
Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call
- Press releasePRNewswire
Shoulder Innovations Initiates Commercial Launch of the InSet® Go
- Press releasePRNewswire
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
- Press releasePRNewswire
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
- Press releasePRNewswire
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
- Press releasePRNewswire
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
- Press releasePRNewswire
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
- Press releasePRNewswire
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook
- Press releasePRNewswire
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference
- Press releasePRNewswire
Shoulder Innovations to Report Second Quarter 2026 Financial Results on August 6, 2026
- Press releasePRNewswire
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
- Press releasePRNewswire
Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- News
Shoulder Innovations Q1 2026 Earnings Call Transcript
- Press releasePRNewswire
Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
- News
Earnings Scheduled For May 13, 2026
- Press releasePRNewswire
Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
- Press releasePRNewswire
Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026
- Press releasePRNewswire
Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For March 10, 2026
- Press releasePRNewswire
Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors
- Press releasePRNewswire
Shoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
- Press releasePRNewswire
Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
- Press releasePRNewswire
Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Press releasePRNewswire
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
- Press releasePRNewswire
Shoulder Innovations to Participate in the Piper Sandler 37th Annual Healthcare Conference
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsMohd Haider
Shoulder Innovations (SI) Stock Rose 21% After-Hours: Here's Why
- Press releasePRNewswire
Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
- News
Earnings Scheduled For November 11, 2025
- Press releasePRNewswire
Shoulder Innovations to Participate in the Jefferies Global Healthcare Conference
- Press releasePRNewswire
Shoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025
- Press releasePRNewswire
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.